FDA authorizes marketing of the first genetic test for Fragile X Syndrome Medical Dialogues Bureau25 Feb 2020 2:09 PM ISTUS: The U.S. Food and Drug Administration has authorized marketing of the test to detect a genetic condition known as Fragile X Syndrome (FXS), the...
